Advertisement
Advertisement
Trending on HCPLive
1
Zumilokibart Rapidly Suppresses FeNO in Phase 1b Asthma Data: Mario Castro, MD
2
GRI-0621 Improves FVC, Reduces Fibrotic Biomarkers in IPF
3
BEAM-302 Base Editing Sustains Protective AAT, With John Hurst, MBBS, PhD
4
KT-621 Achieves Deep STAT6 Degradation, Initial Respiratory, Skin Gains
5